An official website of the United States government
Resistance to antibiotics is a serious and worsening threat to human health worldwide, and there is an urgent need to develop new antibiotics that can avert it. One possible solution is the development of compounds that possess multiple modes of action, requiring at least two mutations to acquire resistance. Compound SCH-79797 both avoids resistance and has two mechanisms of action: one inhibiting the folate pathway, and a second described as “membrane permeabilization”; however, the mechanism by which membranes from bacterial cells, but not the host, are disrupted has remained mysterious. The opening of the bacterial mechanosensitive channel of large conductance, MscL, which ordinarily serves the physiological role of osmotic emergency release valves gated by hypoosmotic shock, has been previously demonstrated to affect bacterial membrane permeabilization. MscL allows the rapid permeabilization of both ions and solutes through the opening of the largest known gated pore, which has a diameter of 30 Å. We found that SCH-79797 and IRS-16, a more potent derivative, directly bind to the MscL channel and produce membrane permeabilization as a result of its activation. These findings suggest that possessing or adding an MscL-activating component to an antibiotic compound could help to lower toxicity and evade antibiotic resistance.
more »
« less
In Silico Screen Identifies a New Family of Agonists for the Bacterial Mechanosensitive Channel MscL
MscL is a highly conserved mechanosensitive channel found in the majority of bacterial species, including pathogens. It functions as a biological emergency release valve, jettisoning solutes from the cytoplasm upon acute hypoosmotic stress. It opens the largest known gated pore and has been heralded as an antibacterial target. Although there are no known endogenous ligands, small compounds have recently been shown to specifically bind to and open the channel, leading to decreased cell growth and viability. Their binding site is at the cytoplasmic/membrane and subunit interfaces of the protein, which has been recently been proposed to play an essential role in channel gating. Here, we have targeted this pocket using in silico screening, resulting in the discovery of a new family of compounds, distinct from other known MscL-specific agonists. Our findings extended the study of this functional region, the progression of MscL as a viable drug target, and demonstrated the power of in silico screening for identifying and improving the design of MscL agonists.
more »
« less
- Award ID(s):
- 1955260
- PAR ID:
- 10325207
- Date Published:
- Journal Name:
- Antibiotics
- Volume:
- 11
- Issue:
- 4
- ISSN:
- 2079-6382
- Page Range / eLocation ID:
- 433
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
The global rise of antibiotic-resistant pathogens has created an imperative to discover novel antimicrobial strategies. Traditional antibiotics predominantly target essential bacterial processes, such as cell division, DNA replication, transcription, and translation, but few new agents targeting these pathways have emerged in recent decades. We explored an alternative approach by identifying small molecules that hyperactivate the bacterial ClpP protease, thereby inducing uncontrolled proteolysis and ultimately leading to bacterial cell death. Leveraging the known binding interactions of the peptide antibiotic ADEP4 with ClpP, we performed high-throughput in silico screening. Molecular docking simulations prioritized compounds based on predicted binding affinity (kcal/mol), complemented by structural chemistry evaluation and in silico pharmacokinetic profiling. AGI‑6780 emerged as a lead compound with high predicted affinity for the ClpP active site. In vitro assays showed that AGI‑6780 effectively inhibits a panel of Gram-positive bacteria by targeting ClpP. It also exhibits synergy with the antibiotic rifampicin and has minimal cytotoxicity on human cell lines. AGI‑6780 is a promising antimicrobial agent that uniquely exploits ClpP, an unconventional bacterial target.more » « less
-
Tropomyosin kinase receptor B (TrkB) has been explored as a therapeutic target for neurological and psychiatric disorders. However, the development of TrkB agonists was hindered by our poor understanding of the TrkB agonist binding location and affinity (both affect the regulation of disorder types). This motivated us to develop a combined computational and experimental approach to study TrkB binders. First, we developed a docking method to simulate the binding affinity of TrkB and binders identified by our magnetic drug screening platform from Gotu kola extracts. The Fred Docking scores from the docking computation showed strong agreement with the experimental results. Subsequently, using this screening platform, we identified a list of compounds from the NIH clinical collection library and applied the same docking studies. From the Fred Docking scores, we selected two compounds for TrkB activation tests. Interestingly, the ability of the compounds to increase dendritic arborization in hippocampal neurons matched well with the computational results. Finally, we performed a detailed binding analysis of the top candidates and compared them with the best-characterized TrkB agonist, 7,8-dyhydroxyflavon. The screening platform directly identifies TrkB binders, and the computational approach allows for the quick selection of top candidates with potential biological activities based on the docking scores.more » « less
-
Assembling transmembrane proteins on organic electronic materials is one promising approach to couple biological functions to electrical readouts. A biosensing device produced in such a way would enable both the monitoring and regulation of physiological processes and the development of new analytical tools to identify drug targets and new protein functionalities. While transmembrane proteins can be interfaced with bioelectronics through supported lipid bilayers (SLBs), incorporating functional and oriented transmembrane proteins into these structures remains challenging. Here, we demonstrate that cell-free expression systems allow for the one-step integration of an ion channel into SLBs assembled on an organic conducting polymer, poly(3,4-ethylenedioxythiophene) polystyrenesulfonate (PEDOT:PSS). Using the large conductance mechanosensitive channel (MscL) as a model ion channel, we demonstrate that MscL adopts the correct orientation, remains mobile in the SLB, and is active on the polyelectrolyte surface using optical and electrical readouts. This work serves as an important illustration of a rapidly assembled bioelectronic platform with a diverse array of downstream applications, including electrochemical sensing, physiological regulation, and screening of transmembrane protein modulators.more » « less
-
null (Ed.)To accelerate materials discovery, computational methods such as inverse materials design have been proposed to predict the properties of target compounds of interest for specific applications. This in silico process can be used to guide subsequent synthesis and characterization. Inverse design is especially relevant for the field of organic molecules, for which there are nearly infinite synthetic modifications possible. With a target application of UV-absorbing, visibly transparent solar cells in mind, we calculated the orbital and transition energies of over 360 possible coronene derivatives. Our screening, or the constraints we imposed on the calculated series, resulted in the selection of three new derivatives, namely contorted pentabenzocoronene (cPBC), contorted tetrabenzocoronene (cTBC), and contorted tetrabenzofuranylbenzocoronene (cTBFBC) for synthesis and characterization. Our materials characterization found agreement between our calculated and experimental energy values, and through testing of these materials in organic photovoltaic (OPV) devices, we fabricated solar cells with an open-circuit voltage of 1.84 V and an average visible transparency of 88% of the active layer; both quantities exceed previous records for visibly transparent coronene-based solar cells. This work highlights the promise of inverse materials design for future materials discovery, as well as improvements to an exciting application of UV-targeted solar cells.more » « less
- Free Publicly Accessible Full Text
-
Accepted Manuscript
- Journal Article:
- https://doi.org/10.3390/antibiotics11040433
